Publication #8000

Reference
Drug alert 38/2023
Name
Drug alert class 4 – 38 2023 – Class 4 medicines defect information – caution in use – Zinacef 250mg powder for solution for injection or infusion vials
Categories
Scottish Government Drug Alerts
Organization
Scottish Government Health and Social Care Directorates
Keywords
NHS SCOTLAND DRUGS SAFETY RISKS PHARMACEUTICAL INDUSTRY MEDICINES RECALL
Description
Sandoz, the Marketing Authorisation Holder (MAH), has detected that information on the diluents in the Patient Information Leaflet (PIL) and Summary of Product Characteristics (SmPC) of cefuroxime offer possibility for both intramuscular (IM) and intravenous (IV) administration. The PIL and SmPC state that cefuroxime sodium is compatible with aqueous solutions containing up to 1% lidocaine hydrochloride. However, dilution with lidocaine is intended only for intramuscular (IM) use. As this is not explicitly mentioned, the MAH considers this to pose a potential for medication errors.

Contact Name
Annie Gonelli
Contact Email
Contact Address
Contact Phone

Created
2023-10-23 00:00:00


Click to go back to homepage